Additional file 1: of Good response to PAH-targeted drugs in a PVOD patient carrying Biallelic EIF2AK4 mutation
journal contributionposted on 01.10.2018 by Li Liang, Hua Su, Xiuqing Ma, Ruifeng Zhang
Any type of content formally published in an academic journal, usually following a peer-review process.
The detailed treatment course of the PVOD patient is below. (DOC 25 kb)